KANNAPOLIS, NC, USA (July 6th, 2020) – Eremid™ Research Services Inc., (Eremid) has been established as the new name for the commercial arm of the 501(c)(3) non-profit, research organization – DHMRI.
Eremid continues to specialize in the provision of genomics, metabolomics, NMR and vivarium research services, with dedicated expertise and cutting-edge instrumentation essential to furthering scientific understanding in areas including Human Health, Food & Nutrition, and AgBiotech.
The Eremid team has over 10 years’ contract research experience in the advancement of knowledge and understanding in wellness, health, and longevity for humans and companion animals. Working with both commercial and academic organizations, Eremid has supported the development of targeted nutritional and pharmaceutical products, improved crops, and healthier and more sustainable foods.
The company offers a “multi-omics” approach, working with clients across the globe to develop experimental design and analysis that combines genomics and metabolomics services to generate fast and accurate results, and maximize the data gained from their samples.
As one of the most capable genomics laboratories in North America, Eremid provides top-of-the-range instrumentation and research expertise in genomics, transcriptomics, epigenetics, and bioinformatics, using novel and customized methods, assays, and protocols to suit a client’s exact needs. Eremid’s highly experienced metabolomics team provides comprehensive investigation of metabolites and metabolism, supporting clients with study design, sample extraction, analysis, and data visualization and interpretation. The company’s cutting-edge laboratories are equipped with multiple mass spectrometers and nuclear magnetic resonance (NMR) platforms, including an ultra-high field 950 MHz NMR spectrometer, capable of characterizing small molecules, impurities, and metabolites at high resolution, even at very low concentrations.
Eremid’s customer-focused commitment – including detailed project management, and regular, proactive updates on project status – is at the heart of the company’s offering, as emphasized by Steve Watkins, CEO, BCD Biosciences: “Working with Eremid has been a pleasure. We received excellent data with a very fast turnaround and appreciated the attentive and helpful project management!”
Commenting on the launch of the rebranded commercial services offering, Julian Abery, Eremid’s Chief Business Officer said: “The relaunch of our established services under the Eremid brand marks a significant new phase in the development of our facility, at a time when companies in the food, agriculture, and health sectors are increasingly seeing the value of accessing the expertise of dedicated contract research teams. Eremid has one of the best-equipped labs in North America, but what really sets us apart is our multi-omics expertise, and our customized, collaborative project design. By focusing on the science at hand and understanding the customer need, we deliver data that enables companies to develop products with improved characteristics, and enhanced societal and monetary value.”
Eremid™ Research Services Inc.
Eremid is a contract research organization with over 10 years specialist expertise, focused on delivering high quality science and research enhancing data through customized, collaborative projects designed to meet the needs of our clients. We combine expertise, world-class facilities, including an in-house vivarium, and cutting-edge instrumentation in genomics, metabolomics and NMR, to support companies involved in the research and development of products for Human Health, Food & Nutrition and AgBiotech
Eremid is the commercial arm of DHMRI, a 501(c)(3) non-profit organization supporting UNC System, Duke University, the North Carolina Research Campus and academic researchers and other non-profit organizations, world-wide, to deliver advancements in our knowledge and understanding of human wellness, health and longevity.